Current and future management of EGFR-positive NSCLC - European Medical Journal

PLEASE CONFIRM THE DETAILS BELOW TO CONTINUE

This educational webinar has been organised and funded by The Janssen Pharmaceutical Companies of Johnson & Johnson. The content of the podcast has not been approved for distribution to United Kingdom (UK) healthcare professionals.

Continue

Current and future management of EGFR-positive NSCLC

Oncology

With: Dr. Sackier (Moderator), Dr. Moreno (KOL) and Prof. Vansteenkiste (KOL)

Job bag: CP-329213

Date of prep: July 2022

This educational webinar has been organised and funded by The Janssen Pharmaceutical Companies of Johnson & Johnson. The content of the webinar has not been approved for distribution to United Kingdom (UK) healthcare professionals.

 

 

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

We’ve noticed you’re accessing
from North/South America.